Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedJan 06, 2026
DataAggregated Company Financials
Companies42
- 7D2.6%
- 3M1.5%
- 1Y5.5%
- YTD0%
In the last week, the Healthcare Services industry is up 2.6%, with Sanbo Hospital Management Group leading the way, up 17%. Meanwhile, Luyan PharmaLtd actually underperformed within the industry, shrinking 7.2% in the last week. This means that the industry has gained 5.5% over the past year. As for the next few years, earnings are expected to grow by 23% per annum.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 06 Jan 2026 | CN¥643.4b | CN¥1.1t | CN¥24.2b | 33.5x | 26.6x | 0.6x |
| Thu, 04 Dec 2025 | CN¥643.4b | CN¥1.1t | CN¥24.2b | 34x | 26.6x | 0.6x |
| Sat, 01 Nov 2025 | CN¥646.1b | CN¥1.1t | CN¥24.2b | 36.1x | 26.7x | 0.6x |
| Mon, 29 Sep 2025 | CN¥593.5b | CN¥1.0t | CN¥21.9b | 34.8x | 27.1x | 0.6x |
| Wed, 27 Aug 2025 | CN¥632.6b | CN¥988.0b | CN¥20.7b | 33.6x | 30.5x | 0.6x |
| Fri, 25 Jul 2025 | CN¥604.9b | CN¥988.6b | CN¥20.9b | 32.2x | 28.9x | 0.6x |
| Sun, 22 Jun 2025 | CN¥549.5b | CN¥988.6b | CN¥20.9b | 29.2x | 26.3x | 0.6x |
| Tue, 20 May 2025 | CN¥565.9b | CN¥991.4b | CN¥21.0b | 31.1x | 27x | 0.6x |
| Thu, 17 Apr 2025 | CN¥553.0b | CN¥986.9b | CN¥20.5b | 29x | 26.9x | 0.6x |
| Sat, 15 Mar 2025 | CN¥609.1b | CN¥994.3b | CN¥21.5b | 33.5x | 28.3x | 0.6x |
| Mon, 10 Feb 2025 | CN¥570.8b | CN¥994.3b | CN¥21.5b | 30.1x | 26.5x | 0.6x |
| Wed, 08 Jan 2025 | CN¥549.5b | CN¥994.3b | CN¥21.5b | 28.9x | 25.5x | 0.6x |
| Fri, 06 Dec 2024 | CN¥621.4b | CN¥994.3b | CN¥21.5b | 34.3x | 28.9x | 0.6x |
| Sun, 03 Nov 2024 | CN¥588.1b | CN¥994.8b | CN¥21.5b | 33.1x | 27.3x | 0.6x |
| Tue, 01 Oct 2024 | CN¥625.9b | CN¥984.5b | CN¥22.0b | 37.1x | 28.4x | 0.6x |
| Thu, 29 Aug 2024 | CN¥470.2b | CN¥989.5b | CN¥22.6b | 23.3x | 20.8x | 0.5x |
| Sat, 27 Jul 2024 | CN¥493.7b | CN¥988.5b | CN¥22.5b | 26.6x | 21.9x | 0.5x |
| Mon, 24 Jun 2024 | CN¥513.8b | CN¥988.5b | CN¥22.5b | 27.6x | 22.8x | 0.5x |
| Wed, 22 May 2024 | CN¥588.8b | CN¥988.3b | CN¥22.4b | 33.7x | 26.3x | 0.6x |
| Fri, 19 Apr 2024 | CN¥571.5b | CN¥987.0b | CN¥19.4b | 29.7x | 29.4x | 0.6x |
| Sun, 17 Mar 2024 | CN¥622.8b | CN¥977.8b | CN¥20.1b | 30x | 31x | 0.6x |
| Tue, 13 Feb 2024 | CN¥604.0b | CN¥977.8b | CN¥20.1b | 29.1x | 30.1x | 0.6x |
| Thu, 11 Jan 2024 | CN¥641.4b | CN¥976.7b | CN¥19.7b | 28.8x | 32.6x | 0.7x |
| Sat, 09 Dec 2023 | CN¥691.3b | CN¥976.1b | CN¥19.9b | 30.6x | 34.7x | 0.7x |
| Mon, 06 Nov 2023 | CN¥725.6b | CN¥976.1b | CN¥19.9b | 31.4x | 36.4x | 0.7x |
| Wed, 04 Oct 2023 | CN¥734.1b | CN¥982.2b | CN¥21.2b | 29.8x | 34.7x | 0.7x |
| Fri, 01 Sep 2023 | CN¥723.5b | CN¥982.1b | CN¥21.2b | 29.6x | 34.1x | 0.7x |
| Sun, 30 Jul 2023 | CN¥797.3b | CN¥954.7b | CN¥23.1b | 26x | 34.5x | 0.8x |
| Tue, 27 Jun 2023 | CN¥762.2b | CN¥948.1b | CN¥23.0b | 25.5x | 33.2x | 0.8x |
| Thu, 25 May 2023 | CN¥832.3b | CN¥948.0b | CN¥23.0b | 27.5x | 36.3x | 0.9x |
| Sat, 22 Apr 2023 | CN¥818.8b | CN¥914.6b | CN¥26.5b | 30.7x | 30.9x | 0.9x |
| Mon, 20 Mar 2023 | CN¥830.8b | CN¥907.3b | CN¥26.8b | 30.6x | 31.1x | 0.9x |
| Wed, 15 Feb 2023 | CN¥871.8b | CN¥906.0b | CN¥26.4b | 31.9x | 33x | 1x |
| Fri, 13 Jan 2023 | CN¥818.7b | CN¥905.7b | CN¥26.4b | 29.6x | 31.1x | 0.9x |
Price to Earnings Ratio
31.1x
Current Industry PE
- Investors are relatively neutral on the Chinese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 29.2x.
- The industry is trading close to its 3-year average PS ratio of 0.66x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 2.8% per year over the last three years.
- Meanwhile revenues for these companies have grown 6.4% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 1.87% | |
| Healthcare | 2.69% | |
| Healthcare Services | 2.56% | |
| Healthcare Services | 5.39% | |
| Healthcare Facilities | 3.70% | |
| Healthcare Distributors | 1.42% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 180x.
- Analysts are expecting annual earnings growth of 59.7%, which is higher than its past year's earnings decline of 1.8% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 19.1x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 60% over the next 5 years.
- This is better than its past earnings decline of 1.8% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 301293 Sanbo Hospital Management Group | CN¥84.94 | 41.8% +CN¥5.1b | 101.5% | PE205x | |
| 300015 Aier Eye Hospital Group | CN¥11.40 | 3.4% +CN¥3.4b | -9.0% | PE32.9x | |
| 000516 Xi'an International Medical Investment | CN¥5.19 | 20.1% +CN¥1.9b | 3.8% | PS2.8x | |
| 002173 Innovative Medical ManagementLtd | CN¥26.03 | 19.4% +CN¥1.9b | 214.0% | PS14.3x | |
| 300244 Dian Diagnostics GroupLtd | CN¥17.57 | 13.9% +CN¥1.3b | 61.5% | PS1x |